Tecovirimat SIGA is a medicine to treat smallpox, monkeypox and cowpox, three infections caused by viruses belonging to the same family (orthopoxviruses). It is also used to treat complications that can happen following vaccination against smallpox. Tecovirimat SIGA is used in adults and children weighing at least 13 kg. It contains the active substance tecovirimat.
Therapeutic Indication
### Therapeutic indication Tecovirimat SIGA is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg: - Smallpox - Monkeypox - Cowpox Tecovirimat SIGA is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4.4 and 5.1). Tecovirimat SIGA should be used in accordance with official recommendations.
Therapeutic Area (MeSH)
N/AATC Code
J05AX24
ATC Item
tecovirimat
Pharmacotherapeutic Group
Antivirals for systemic use
Active Substance (Summary)
INN / Common Names
N/AEMA Name
Tecovirimat SIGA
Medicine Name
Tecovirimat SIGA
Aliases
N/ANo risk management plan link.
